Review Article

The Spectra of Disease-Causing Mutations in the Ferroportin 1 (SLC40A1) Encoding Gene and Related Iron Overload Phenotypes (Hemochromatosis Type 4 and Ferroportin Disease)

Table 1

Comprehensive list of published SCL40A1 variants.

ExonNucleotide changeAmino acid changeLocalization in proteinIndex cases (=) (PMID)Functional classificationACMG/AMP classificationDiagnosis
In vitro findings (PMID)Structural predictions (this study)

3c.190T>Ap.Tyr64AsnTM21 (12857562)Gain-of-function (15831700, 15692071, 19709084, 19383972, and 23943237)PathogenicHemochromatosis type 4

3c.190T>Cp.Tyr64HisTM21 (25396007)DeleteriousLikely pathogenicHemochromatosis type 4

3c.205G>Ap.Ala69ThrTM22 (27177411, 29154924)Gain-of-function (24859227, 29154924)Likely pathogenicHemochromatosis type 4

3c.214G>Tp.Val72PheTM21 (18177470)Gain-of-function (29237594)Likely pathogenicHemochromatosis type 4

3c.230C>Ap.Ala77AspTM23 (10471458, 15951560, and 18160317)Loss-of-function (15831700, 15692071, 16885049, 23943237, 19846751, 15935710, 23784628, 21396368, 24714983, 24859227, 30002125, and 32450003)PathogenicFerroportin disease

3c.238G>Ap.Gly80SerTM212 (16135412, 16885049, 17052926, 18420432, 21094556, 24370385, and 24714983)Loss-of-function (21094556, 24714983, and 16885049)PathogenicFerroportin disease

3c.239G>Tp.Gly80ValTM21 (16351644)DeleteriousLikely pathogenicFerroportin disease

3c.252C>Gp.Asp84GluTM21 (28681497)Loss-of-function (28681497)Likely pathogenicFerroportin disease

3c.262A>Gp.Arg88GlyTM33 (17951290, 24714983)Loss-of-function (23943237, 24714983)Likely pathogenicFerroportin disease

3c.263G>Cp.Arg88ThrTM31 (16257244)DeleteriousPathogenicFerroportin disease

3c.263G>Tp.Arg88IleTM31 (33385755)DeleteriousPathogenicFerroportin disease

4c.386T>Cp.Leu129ProTM41 (24644245)VUSUnexplained hyperferritinemia

5c.430A>Cp.Asn144HisTM41 (11431687)Gain-of-function (15831700, 15692071, 15956209, 19846751, 15935710, 23784628, 24859227, 19937651, and 30002125)PathogenicHemochromatosis type 4

5c.430A>Gp.Asn144AspTM41 (15030991)Gain-of-function (15692071, 19383972, and 29237594)PathogenicHemochromatosis type 4

5c.431A>Cp.Asn144ThrTM41 (12865285)Gain-of-function (19383972, 19846751)PathogenicHemochromatosis type 4

5c.431A>Gp.Asn144SerTM41 (18403150)DeleteriousLikely pathogenicHemochromatosis type 4

5c.454A>Tp.Ile152PheTM41 (18713659)Loss-of-function (23784628, 18713659)Likely pathogenicFerroportin disease

5c.469G>Tp.Asp157TyrTM41 (24714983)Loss-of-function (24714983)PathogenicFerroportin disease

5c.470A>Gp.Asp157GlyTM43 (12730114, 24714983)Loss-of-function (15935710, 15956209, 16457665, and 24714983)Likely pathogenicFerroportin disease

5c.469G>Ap.Asp157AsnTM42 (18177470, 29154924)DeleteriousLikely pathogenicFerroportin disease

5c.470A>Cp.Asp157AlaTM43 (20230395, 20533066, and 26183747)DeleteriousLikely pathogenicFerroportin disease

5c.474G>T
c.474G>C
p.Trp158CysTM42 (21396368, 28110135)Loss-of-function (21396368)PathogenicFerroportin disease

5c.479T>Cp.Val160AlaTM41 (34828384)VUSUnexplained hyperferritinemia

5c.484_486delp.Val162delTM420 (12091366, 12091367, 12123233, 12406098, 15671438, 15753550, 15986403, 17052926, 17997113, 18160317, 24714983, 25742196, 25744502, 29154924, and 31689754)Loss-of-function (15692071, 15935710, 15956209, 17729390, 28681497, 19846751, 16457665, and 24714983)PathogenicFerroportin disease

6c.521A>Tp.Asn174IleTM53 (16135412, 16885049)Loss-of-function (24767627, 23784628, 16885049, and 29154924)Likely pathogenicFerroportin disease

6c.533G>Ap.Arg178GlnTM59 (17997113, 17951290, 30002125, and 32450003)Loss-of-function (30002125, 32450003)PathogenicFerroportin disease

6c.536G>Cp.Arg179ThrTM51 (34828384)VUSUnexplained hyperferritinemia

6c.539T>Cp.Ile180ThrTM53 (16257244, 22890139, and 24714983)Neutral (24714983)Likely benignUnexplained hyperferritinemia

6c.541G>Ap.Asp181AsnTM51 (29154924)Loss-of-function (29154924)PathogenicFerroportin disease

6c.542A>Tp.Asp181ValTM54 (16351644, 24714983, and 24859227)Loss-of-function (24767627, 24859227, and 24714983)PathogenicFerroportin disease

6c.546G>Tp.Gln182HisTM51 (12730114)Gain-of-function (15935710, 15956209, and 16457665)Likely pathogenicHemochromatosis type 4

6c.553A>Gp.Asn185AspTM52 (16111902, 21199650)Loss-of-function (23943237)PathogenicFerroportin disease

6c.610G>Cp.Gly204ArgTM61 (29154924)Gain-of-function (29154924)PathogenicHemochromatosis type 4

6c.610G>Ap.Gly204SerTM62 (21199650, 21411349)Gain-of-function (23943237, 29237594)PathogenicHemochromatosis type 4

6c.626C>Tp.Ser209LeuTM62 (27896572, 28110135)VUSUnexplained hyperferritinemia

6c.689C>Ap.Thr230AsnIC31 (24714983)Neutral (24714983)Likely benignUnexplained hyperferritinemia

6c.698T>Cp.Leu233ProIC32 (18713659, 24714983)Loss-of-function (18713659, 24714983)Likely pathogenicFerroportin disease

6c.697C>Gp.Leu233ValIC32 (32360131)DeleteriousLikely pathogenicFerroportin disease

6c.718A>Gp.Lys240GluIC31 (21175851)Gain-of-function (22682227)Likely pathogenicHemochromatosis type 4

6c.744G>Tp.Gln248HisIC34 (14636642, 14636644, and 24714983)Neutral (15692071, 15831700, 23065513, and 24714983)BenignUnexplained hyperferritinemia

7c.797T>Cp.Met266ThrIC31 (24714983)Neutral (24714983)Likely benignUnexplained hyperferritinemia

7c.809A>Tp.Asp270ValIC32 (15338274, 22584997)Gain-of-function (29237594)Likely pathogenicHemochromatosis type 4

7C.887G>Ap.Arg296GlnIC31 (29154924)Loss-of-function (29154924)Likely pathogenicFerroportin disease

7c.968G>Tp.Gly323ValTM71 (12730114)Loss-of-function (15935710, 15956209, and 16457665)Likely pathogenicFerroportin disease

7c.977G>Cp.Cys326SerTM71 (15727899)Gain-of-function (29237594, 19383972)PathogenicHemochromatosis type 4

7c.977G>Ap.Cys326TyrTM71 (19342478)Gain-of-function (15692071, 15831700, 23784628, 19937651, 30002125, 32450003, 23065513, 21396368, 24859227, 28681497, and 24714983)PathogenicHemochromatosis type 4

7c.977G>Tp.Cys326PheTM71 (26059880)DeleteriousLikely pathogenicHemochromatosis type 4

7c.997T>Cp.Tyr333HisTM73 (30500107)Gain-of-function (30500107)Likely pathogenicHemochromatosis type 4

7c.1014T>Gp.Ser338ArgTM81 (17383046)Gain-of-function (17383046, 19846751, and 29237594)PathogenicHemochromatosis type 4

7c.1035G>Cp.Leu345PheTM81 (24714983)Neutral (24714983)Likely benignUnexplained hyperferritinemia

7c.1049C>Ap.Ala350AspTM81 (34828384)VUSUnexplained hyperferritinemia

7c.1051A>Gp.Ile351ValTM81 (24714983)Neutral (24714983)Likely benignUnexplained hyperferritinemia

7c.1328C>Tp.Pro443LeuEC51 (24714983)Neutral (24714983)BenignUnexplained hyperferritinemia

7c.1402G>Ap.Gly468SerTM101 (18160816)Loss-of-function (splicing defect) (33341511)Likely pathogenicFerroportin disease

8c.1467A>Cp.Arg489SerTM111 (16258219)DeleteriousLikely pathogenicFerroportin disease

8c.1466G>Ap.Arg489LysTM111 (19937651)Loss-of-function (19937651)PathogenicFerroportin disease

8c.1468G>Ap.Gly490SerTM113 (17951290, 24714983)Loss-of-function (24714983)PathogenicFerroportin disease

8c.1469G>Ap.Gly490AspTM119 (12873829, 24714983)Loss-of-function (15692071, 15956209, and 24714983)Likely pathogenicFerroportin disease

8c.1481G>Ap.Gly494AspTM111 (34828384)DeleteriousLikely pathogenicFerroportin disease

8c.1502A>Gp.Tyr501CysTM111 (19709084)Gain-of-function (19709084, 24767627, and 29237594)Likely pathogenicHemochromatosis type 4

8c.1510G>Ap.Asp504AsnTM111 (24714983)Gain-of-function (24714983, 29237594)Likely pathogenicHemochromatosis type 4

8c.1520A>Gp.His507ArgTM113 (21396368, 27629970, and 33673803)Gain-of-function (21396368, 29237594)Likely pathogenicHemochromatosis type 4

8c.1531G>Ap.Val511IleTM111 (30500107)VUSUnexplained hyperferritinemia

8c.1592T>Cp.Val531AlaTM111 (34828384)VUSUnexplained hyperferritinemia

8c.1681A>Gp.Arg561GlyC-ter2 (19066423, 24714983)Neutral (24714983)BenignUnexplained hyperferritinemia

SLC40A1 variants are documented based on GenBank accession number NM_014585.5. This table does not include three noncoding variations (c.-181A>G, c.-428-427GG>TT, and c.-59-45del) whose functional impact is unknown and nine missense variations (p.Ala45Glu, p.Ala69Val, p.Ser71Phe, p.Trp158Leu, p.Asn185Thr, p.Ala232Asp, p.Gly267Asp, p.Arg371TRp, and p.Arg371Gln) due to the lack of individual phenotypic information ([71]; [72]; [73]; [21]; [74]). Given our predictions in the context of the SLC40A1 3D structure (pdb 6WBV; Figure 3), we propose to use the supporting evidence code PP5 for the p.Gly494Asp variant and classify it in class 4 (instead of class 3); all other variants discussed in Section 2.3 are rated as class 4 or class 5 regardless of the PP5 criteria.